162 related articles for article (PubMed ID: 9025083)
41. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K
J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
43. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
44. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus infection in sarcomatoid renal cell carcinoma tissues.
Kim KH; Han EM; Lee ES; Park HS; Kim I; Kim YS
BJU Int; 2005 Sep; 96(4):547-52. PubMed ID: 16104908
[TBL] [Abstract][Full Text] [Related]
47. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
48. Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides.
De Francesco MA; Gargiulo F; Esteban P; Calzavara-Pinton PG; Venturini M; Perandin F; Baronio M; Pollara C; Terlenghi L; Manca N
J Med Microbiol; 2004 May; 53(Pt 5):381-387. PubMed ID: 15096546
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8.
Ba Abdullah MM; Palermo RD; Palser AL; Grayson NE; Kellam P; Correia S; Szymula A; White RE
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904201
[TBL] [Abstract][Full Text] [Related]
50. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
51. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
52. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders.
Schuster V; Ott G; Seidenspinner S; Kreth HW
Infection; 2000; 28(3):137-42. PubMed ID: 10879636
[TBL] [Abstract][Full Text] [Related]
53. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
Swaminathan S; Tomkinson B; Kieff E
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1546-50. PubMed ID: 1847527
[TBL] [Abstract][Full Text] [Related]
54. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
[TBL] [Abstract][Full Text] [Related]
55. Gene analysis of Epstein-Barr virus-associated lymphomas in Hu-Pbl/SCID chimeras.
Gan R; Xie X; He J; Liu X; Hong L; Tang Y; Liu F; Xie H
Tumori; 2010; 96(3):465-72. PubMed ID: 20845810
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
Allday MJ; Crawford DH; Griffin BE
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
58. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes.
Palefsky JM; Berline J; Greenspan D; Greenspan JS
J Gen Virol; 2002 Feb; 83(Pt 2):317-321. PubMed ID: 11807224
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
Sample J; Kieff EF; Kieff ED
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2741-6. PubMed ID: 7931160
[TBL] [Abstract][Full Text] [Related]
60. [Characteristic of nuclear antigen 1 gene and latent membrane protein 1 gene of Epstein-Barr virus in primary EBV infection in children in Beijing area in 2005-2010].
Ai JH; Xie ZD; Liu CY; Gao LW; Yan J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Oct; 26(5):352-5. PubMed ID: 23547457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
